Clinical Trial Update: Treatment of the Intermediate Vaginal Microbiota With Vaginal Lactobacillus Casei Rhamnosus to Improve Pregnancy Outcome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vaginal Lactobacillus casei rhamnosus to treat intermediate vaginal microbiota with aim of improving pregnancy outcomes; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lactobacillus Infection

Drugs mentioned

• Lactobacillus casei rhamnosus (vaginal formulation) (Lactobacillus casei rhamnosus)

Snippet

Sponsor: Medical University of Vienna | Conditions: Lactobacillus Infection | Phase 3 | Status: COMPLETED